Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha
Browsing: Healthcare
Vor Bio stock rallies post-market on trem-cel study data Source: Seekingalpha
aTyr started at buy by Jefferies, citing efzofitimod potential Source: Seekingalpha
Kits Eyecare announces $10.15M secondary offering Source: Seekingalpha
Fanhua and Shanghai Biotecan Pharmaceuticals enters into cooperation agreement Source: Seekingalpha
Travere gains on full FDA approval for kidney drug Filspari Source: Seekingalpha
GSK’s Nucala succeeds in late-stage study for lung dysfunction, COPD Source: Seekingalpha
Axogen completes marketing submission for Avance Nerve Graft Source: Seekingalpha
Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma Source: Seekingalpha
Psyence Biomedical to acquire drug developer Clairvoyant Source: Seekingalpha